St. Louis MO 克罗恩病临床试验
19项针对 克罗恩病的研究正在 St. Louis及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
招募中2 期
- Specialists In Gastroenterology /ID# 283939, St Louis
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
招募中1 期
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- 以及另外 1 项
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
招募中3 期
- Washington University School of Medicine ( Site 5058), St Louis
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
招募中4 期
- SSM Health Medical Group, Bridgeton · 距离 15 英里
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
招募中2 期
- Washington University /ID# 266938, St Louis
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
招募中3 期
- Washington University School of Medicine, St Louis
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
招募中3 期
- Washington University School of Medicine-Site Number: 8400075, St Louis
- Gateway Gastroenterology-Site Number: 8400097, St Louis
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
招募中3 期
- Gateway Gastroenterology-Site Number: 8400097, St Louis
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
招募中3 期
- Washington University School of Medicine, St Louis
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
招募中2 期
- KAD Clinical Research, St Louis
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
招募中2 期
- SSM Health DePaul Hospital- St. Louis, Bridgeton · 距离 15 英里
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
招募中2 期
- KAD Clinical Research, St Louis
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
招募中4 期
- Washington University School of Medicine, St Louis
DB-3Q for the Treatment of Medically Refractory Crohn's Disease
招募中2 期
- Washington University, St. Louis, St Louis
Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
招募中2 期
- Washington University School of Medicine, St Louis
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
招募中2 期
- Investigational Site Number: 8400013, St Louis
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
招募中2 期
- Mirador Therapeutics Selected Site, Bridgeton · 距离 15 英里
Treatment of Moderate to Severe Refractory Crohn's Disease
招募中1/2 期
- Washington University in St. Louis, St Louis
Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy
招募中观察性研究
- Washington University in St Louis School of Medicine, St Louis
其他城市的 克罗恩病试验
- New York City, NY35 项研究
- Boston, MA19 项研究
- Miami, FL19 项研究
- Cleveland, OH19 项研究
- Tyler, TX17 项研究
- Houston, TX17 项研究
- Orlando, FL17 项研究
- Atlanta, GA17 项研究
- San Antonio, TX15 项研究
- San Diego, CA15 项研究
- Los Angeles, CA15 项研究
- Colorado Springs, CO13 项研究
St. Louis的其他研究
- 非小细胞肺癌73 项研究
- 乳腺癌64 项研究
- 转移性癌症54 项研究
- 结直肠癌50 项研究
- 癌症（所有类型）46 项研究
- 前列腺癌46 项研究
- 肺癌39 项研究
- 卵巢癌38 项研究
- 胰腺癌33 项研究
- 子宫内膜癌29 项研究
- 头颈鳞状细胞癌28 项研究
- 心力衰竭26 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。